Moderator Scott Gottlieb, MD, ended the Oncology Stakeholder Summit, Fall 2015, by asking the panel for closing statements.
Ted Okon, executive director of Community Oncology Alliance, said that one of the biggest things still to be addressed is site neutrality. Although he is encouraged by the Balanced Budget Act—through which, starting in 2017, a visit to a hospital outpatient facility and a visit to a physician’s office will both be paid under the Medicare physician fee schedule—he would like to see a little more legislative work done on the 340B program.
Kavita Patel, MD, MS, referred back to measurements of patient satisfaction, saying that current methods, like consumer assessments and survey tools, are crude and inconsistent. Meanwhile, the private sector continues to innovate in terms of measuring patient satisfaction, but their methods are not being integrated; payment models continue to roll out with mandated requirements for patient satisfaction and patient surveys. Dr Patel said she would like more flexibility in quality metrics, more latitude in clinician performance, and more enforcement with an outcomes-based transparency database.
John L. Fox, MD, MHA, spoke of the developments in the oncology sphere explaining, “Not only do we have the emergence of the oncology care model with CMI, we have new drug therapies especially with the PD-1 and PD-L1 antagonists. We have Medicare now approving advanced care planning and paying physicians and other healthcare providers to talk about what patients’ preferences are and what their priorities and their goals of care are. I think it's an exciting time because the people who will win in this are those who are willing to experiment and collaborate.” Dr Fox would like to have this collaboration across multiple organizations and stakeholders because they will lead the way to more affordable healthcare, and better patient outcomes and experiences.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Industry Experts Tackle Specialty Drug Access Challenges for Employer Benefit Plans
May 2nd 2024Representatives from ICON plc and Symphony Health joined forces at AXS24 to discuss the challenges of managing high-cost specialty drugs and how they influence self-funded employer benefit plan design and employee access to specialty medications.
Read More